Search Results

There are 3160 results for: content related to: Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy

  1. You have free access to this content
    Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue S1, January 2016, Pages: 11–26, J. S. Bajaj

    Version of Record online : 30 NOV 2015, DOI: 10.1111/apt.13435

  2. You have free access to this content
    Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers’ diarrhoea

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 11, June 2010, Pages: 1155–1164, P. LAYER and V. ANDRESEN

    Version of Record online : 11 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04296.x

  3. Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study

    Sleep and Biological Rhythms

    Volume 10, Issue 2, April 2012, Pages: 145–153, Leonard B WEINSTOCK and Suzie ZEISS

    Version of Record online : 4 MAR 2012, DOI: 10.1111/j.1479-8425.2012.00537.x

  4. You have free access to this content
    The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy – a decision analysis

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 8, October 2007, Pages: 1147–1161, E. HUANG, E. ESRAILIAN and B. M. R. SPIEGEL

    Version of Record online : 9 AUG 2007, DOI: 10.1111/j.1365-2036.2007.03464.x

  5. Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study

    Journal of Digestive Diseases

    Volume 16, Issue 11, November 2015, Pages: 665–674, Xin Zeng, Xia Jiao Tang, Xia Sheng, Wu Ni, Hai Guang Xin, Wei Zhong Chen, Cai Feng Jiang, Yong Lin, Jian Shi, Bin Shi, Yue Xiang Chen, Zong Li Yuan and Wei Fen Xie

    Version of Record online : 29 DEC 2015, DOI: 10.1111/1751-2980.12294

  6. You have free access to this content
    Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue S1, January 2016, Pages: 37–49, M. Pimentel

    Version of Record online : 30 NOV 2015, DOI: 10.1111/apt.13437

  7. You have free access to this content
    Rifaximin in the treatment of recurrent Clostridium difficile infection

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 1, January 2013, Pages: 122–128, E. Mattila, P. Arkkila, P. S. Mattila, E. Tarkka, P. Tissari and V.-J. Anttila

    Version of Record online : 24 OCT 2012, DOI: 10.1111/apt.12111

  8. You have free access to this content
    Prevention of Travelers' Diarrhea With Rifaximin in US Travelers to Mexico

    Journal of Travel Medicine

    Volume 17, Issue 2, March/April 2010, Pages: 111–117, Francisco Martinez-Sandoval, Charles D. Ericsson, Zhi-Dong Jiang, Pablo C. Okhuysen, Juan H.M. Meléndez Romero, Norma Hernandez, William P. Forbes, Audrey Shaw, Enoch Bortey and Herbert L. DuPont

    Version of Record online : 24 JAN 2010, DOI: 10.1111/j.1708-8305.2009.00385.x

  9. You have free access to this content
    Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue S1, January 2016, Pages: 27–36, R. B. Sartor

    Version of Record online : 30 NOV 2015, DOI: 10.1111/apt.13436

  10. You have full text access to this OnlineOpen article
    Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 1, January 2015, Pages: 39–45, J. S. Bajaj, A. C. Barrett, E. Bortey, C. Paterson and W. P. Forbes

    Version of Record online : 22 OCT 2014, DOI: 10.1111/apt.12993

  11. Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 36, Issue 3, March 2016, Pages: 300–316, Anastasia Rivkin and Sergey Rybalov

    Version of Record online : 11 MAR 2016, DOI: 10.1002/phar.1712

  12. The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α

    Liver International

    Volume 36, Issue 9, September 2016, Pages: 1295–1303, James G. Orr, Craig J. Currie, Ellen Berni, Anurag Goel, Kieran J. Moriarty, Ashish Sinha, Fiona Gordon, Anne Dethier, John F. Dillon, Katie Clark, Paul Richardson, Paul Middleton, Vishal Patel, Debbie Shawcross, Helen Preedy, Richard J. Aspinall and Mark Hudson

    Version of Record online : 5 APR 2016, DOI: 10.1111/liv.13111

  13. You have free access to this content
    Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 8, October 2010, Pages: 1000–1006, M. Furnari, A. Parodi, L. Gemignani, E. G. Giannini, S. Marenco, E. Savarino, L. Assandri, V. Fazio, D. Bonfanti, S. Inferrera and V. Savarino

    Version of Record online : 18 AUG 2010, DOI: 10.1111/j.1365-2036.2010.04436.x

  14. You have free access to this content
    Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 11-12, December 2012, Pages: 1084–1093, P. Meyrat, E. Safroneeva and A. M. Schoepfer

    Version of Record online : 16 OCT 2012, DOI: 10.1111/apt.12087

  15. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy

    Liver International

    Volume 36, Issue 3, March 2016, Pages: 378–385, Sandeep S. Sidhu, Omesh Goyal, Richard A. Parker, Harsh Kishore and Ajit Sood

    Version of Record online : 17 AUG 2015, DOI: 10.1111/liv.12921

  16. You have free access to this content
    Review article: the antimicrobial effects of rifaximin on the gut microbiota

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue S1, January 2016, Pages: 3–10, H. L. DuPont

    Version of Record online : 30 NOV 2015, DOI: 10.1111/apt.13434

  17. You have free access to this content
    Drug therapy: Rifaximin

    Hepatology

    Volume 52, Issue 4, October 2010, Pages: 1484–1488, Jasmohan S. Bajaj and Oliviero Riggio

    Version of Record online : 29 JUL 2010, DOI: 10.1002/hep.23866

  18. You have full text access to this OnlineOpen article
    Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 10, May 2014, Pages: 1161–1168, P. Schoenfeld, M. Pimentel, L. Chang, A. Lembo, W. D. Chey, J. Yu, C. Paterson, E. Bortey and W. P. Forbes

    Version of Record online : 3 APR 2014, DOI: 10.1111/apt.12735

  19. Impact of rifaximin use for hepatic encephalopathy on the risk of early post-transplant infections in liver transplant recipients

    Clinical Transplantation

    Volume 26, Issue 6, November/December 2012, Pages: 849–852, Hsin-Yun Sun, Marilyn Wagener, Thomas V. Cacciarelli and Nina Singh

    Version of Record online : 20 MAR 2012, DOI: 10.1111/j.1399-0012.2012.01619.x

  20. You have free access to this content
    Efficacy of Rifaximin in Prevention of Travelers' Diarrhea: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials

    Journal of Travel Medicine

    Volume 19, Issue 6, December 2012, Pages: 352–356, Yangmin Hu, Jing Ren, Mei Zhan, Wenlu Li and Haibin Dai

    Version of Record online : 14 SEP 2012, DOI: 10.1111/j.1708-8305.2012.00650.x